Steven M. Paul, M.D.

Executive Vice President, Science and Technology, President of Lilly Research Laboratories

Steven M. Paul, M.D., became executive vice president for science and technology and president of Lilly Research Laboratories, a division of Eli Lilly and Company, in July 2003. He also is a member of the corporate executive committee, operations committee and the company's senior management council, a group of top Lilly executives who implements corporate strategies, ensures corporate performance and identifies corporate issues and opportunities. In 2005, Paul was named Chief Scientific Officer of the Year at one of the annual pharmaceutical achievement awards.

He joined Lilly in April 1993 as vice president of central nervous system discovery and decision phase medical research in LRL and was named vice president, therapeutic area discovery research and clinical investigation, in 1996. Paul became group vice president of therapeutic area discovery research and clinical investigation for LRL in 1998.

Paul received a bachelor of arts degree, magna cum laude with honors, in biology and psychology from Tulane University in 1972. He received a master of science degree in anatomy and neuroanatomy and his doctor of medicine degree, both in 1975, from the Tulane University School of Medicine. Following an internship in neurology at Charity Hospital in New Orleans, he served as a resident in psychiatry and an instructor in the department of psychiatry at The University of Chicago, Pritzker School of Medicine.

Prior to joining Lilly, Paul served as scientific director of the Intramural Research Program of the National Institute of Mental Health (NIMH), in Bethesda, Md.; professor of psychiatry at Tulane University School of Medicine; and chief of the clinical neuroscience branch, as well as chief of the section on preclinical studies at the National Institute of Mental Health (NIMH).

Paul is a member of various professional societies, which include the Tulane Scholars and Fellows; Phi Eta Sigma; Alpha Epsilon Delta; Sigma Xi; Phi Beta Kappa; and the Alpha Omega Alpha Medical Society. He is the recipient of many honors and scientific recognitions, including the A.E. Bennett Award of the Society of Biological Psychiatry, the Foundations' Fund Prize for Research of the American Psychiatric Association and The Distinguished Service Medal of the United States. In 1997, Paul was elected to membership in the Institute of Medicine of the National Academy of Sciences.

Paul has authored or co-authored more than 500 papers and invited book chapters, and he was listed as one of the most highly cited neuroscientists in the world (1980-2000), by the Institute for Scientific Information (I.S.I.), Philadelphia, Pa.

Paul serves on the editorial boards of numerous scientific journals and on several NIH extramural and intramural committees. He also serves chairman on the executive board of PhRMA's Science and Regulatory Committee and serves on the board of BIO (Biotechnology Industry Organization). Paul serves on the board of directors of the Lilly Foundation, the Foundation of the NIH, Butler University and the Indianapolis Zoological Society.